The two executives discuss joining Persica Pharmaceuticals and how they’re driving the company forward with non-opioid pain medication.
Dave Watson
Advertisement
Dave Watson is CEO of Persica Pharmaceuticals.
Articles by Dave Watson
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Pharma Roundup: FDA Approves Truqap Plus Abiraterone and Prednisone, FDA Approves Keytruda and Keytruda Qlex Each in Combination with Welireg
2
How Regulatory Shifts are Impacting the Vaccine Environment
3
What Do You See as The Next Phase of Obesity Innovation?
4
Pharmaceutical Executive Daily: FDA Approves Two Indications of Keytruda in Combination with Welireg
5